Effectiveness of Mabthera in advanced stages B-CLL and for in vivo purging autologous peripheral stem cell transplantation.

被引：0
|
作者：
Shtalrid, M [1 ]
Shvidel, L [1 ]
Klepfish, A [1 ]
Haran, M [1 ]
Berrebi, A [1 ]
机构：
[1] Kaplan Med Ctr, Inst Hematol, Rehovot, Israel
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4916
引用
收藏
页码：293B / 293B
页数：1
相关论文
共 50 条
  • [21] Peripheral hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang, Shirong
    Nademanee, Auayporn P.
    Qian, Dajun
    Dagis, Andrew
    Park, Hyun-Soon
    Fridey, Joy
    Smith, Eileen Patricia
    Snyder, David S.
    Bhatia, Ravi
    Falk, Peter M.
    Kay, Candace
    Kim, Young Sun
    Kogut, Neil Martin
    Palmer, Joycelynne
    Rosenthal, Joseph
    Somlo, George
    Stein, Anthony Selwyn
    Yuan, Shan
    Forman, Stephen J.
    BLOOD, 2006, 108 (11) : 453B - 453B
  • [22] Predictors Of Early Engraftment In Autologous Peripheral Stem Cell Transplantation. A single center experience
    Massoud, Radwan
    Otrock, Zaher
    Haffar, Basel
    Mahfouz, Rami
    Zahreddine, Ammar
    Kreidieh, Nabila
    Nehme, Rita
    Bazarbachi, Ali
    El Cheikh, Jean
    BONE MARROW TRANSPLANTATION, 2018, 53 : 512 - 513
  • [23] First case report of bartonella henselae bacteremia in autologous peripheral stem cell transplantation.
    Niazi, MA
    Zain, J
    Takeshita, K
    Tierno, PM
    Cook, P
    BLOOD, 2000, 96 (11) : 342B - 342B
  • [24] B-cell purging in autologous stem-cell transplantation for non-Hodgkin lymphoma
    Jacobsen, E
    Freedman, A
    LANCET ONCOLOGY, 2004, 5 (12): : 711 - 717
  • [25] EFFICACY OF EX VIVO PURGING WITH CD34 POSITIVE SELECTION DURING AUTOLOGOUS STEM CELL TRANSPLANTATION IN PERIPHERAL T-CELL LYMPHOMAS
    Jeon, Y.
    Min, G.
    Park, S.
    Park, S.
    Yoon, J.
    Lee, S.
    Cho, B.
    Eom, K.
    Kim, Y.
    Min, C.
    Lee, J.
    Cho, S.
    CYTOTHERAPY, 2021, 23 (05) : S74 - S74
  • [26] Effective in vivo purging with rituximab and autologous peripheral blood stem cell transplantation in a woman with CD5 positive primary cutaneous diffuse large B-cell lymphoma
    Goto, H
    Nishio, M
    Endo, T
    Sato, N
    Koizumi, K
    Fujimoto, K
    Sakai, T
    Kumano, K
    Obara, M
    Koike, T
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (06) : 526 - 528
  • [27] Allogeneic stem cell transplantation from related or unrelated donors for B-cell chronic lymphocytic leukemia (B-CLL).
    Pavletic, ZS
    Arrowsmith, ER
    Bierman, PJ
    Goodman, SA
    Vose, JM
    Tarantolo, SR
    Stein, RS
    Greer, JP
    Kollath, JP
    Weisenburger, DD
    Wolff, SN
    Armitage, JO
    Bishop, MR
    BLOOD, 1998, 92 (10) : 288A - 288A
  • [28] In vivo purging with Rituximab before autologous peripheral blood progenitor cell (PBPC) transplantation in lymphoma patients (PTS).
    Salles, G
    Moullet, I
    Charlot, C
    Thieblemont, C
    Bouafia, F
    Dumontet, C
    Espinouse, D
    Coiffier, B
    BLOOD, 1999, 94 (10) : 141A - 141A
  • [29] Infections after autologous CD34 selected peripheral blood stem cell transplantation.
    Crippa, F
    Holmberg, L
    Hooper, H
    Carter, R
    Marr, K
    Bensinger, W
    Chauncey, T
    Corey, L
    Boeckh, M
    BLOOD, 2000, 96 (11) : 586A - +
  • [30] Quality of life improvement in patients with multiple sclerosis after autologous peripheral stem cell transplantation.
    Novik, AA
    Ionova, TI
    Bisaga, GN
    Melnichenko, VY
    Denisov, PI
    Chelombit, LV
    BLOOD, 2001, 98 (11) : 396B - 396B
12345